Long-term outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy.

被引：0
|
作者：
Querques, Lea [1 ]
Bandello, Francesco [1 ]
Corvi, Federico [1 ]
La Spina, Carlo [1 ]
Benatti, Lucia [1 ]
Sarraf, David [2 ]
Freund, K. Bailey [3 ]
Parodi, Maurizio Battaglia [1 ]
Souied, Eric H. [4 ]
Querques, Giuseppe [1 ]
机构：
[1] Univ Vita Salute San Raffaele, IRCCS Osped San Raffaele, Ophthalmol, Milan, Italy
[2] Stein Eye Inst, Los Angeles, CA USA
[3] Vitreous Retina Macula Consultants New York, New York, NY USA
[4] Univ Paris Est Creteil, Creteil, France
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
541
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration
    Wykoff, Charles C.
    Clark, W. Lloyd
    Nielsen, Jared S.
    Brill, Joel V.
    Greene, Laurence S.
    Heggen, Cherilyn L.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (02): : S3 - S15
  • [32] Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degeneration
    Arai, Yusuke
    Takahashi, Hidenori
    Inoda, Satoru
    Tan, Xue
    Sakamoto, Shinichi
    Inoue, Yuji
    Fujino, Yujiro
    Kawashima, Hidetoshi
    Yanagi, Yasuo
    PLOS ONE, 2020, 15 (03):
  • [33] Long term anti-VEGF therapy for neovascular age-related macular degeneration: prognostic factors, treatment benefit and outcome
    Roh, Miin
    Braschler, Marina
    Braschler, Thomas
    Vavvas, Demetrios G.
    Miller, Joan W.
    Kim, Ivana K.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [34] Hyperreflective material evolution patterns during long term anti-VEGF therapy in neovascular age-related macular degeneration
    Pauleikhoff, Daniel
    Yu, Siqing
    Bachmeier, Isabel
    Armendariz, Beatriz Garcia
    Bormann, Eike
    Pauleikhoff, Laurenz
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024,
  • [35] ANTI-VEGF TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN AUSTRALIA
    Finger, Robert
    Fotis, Kathy
    Cummins, Rob
    Heraghty, Julie
    Guymer, Robyn
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 14 - 14
  • [36] Efficacy and outcome predictors of long-term intravitreal anti-VEGF therapy in neovascular age-related macular degeneration following a strict treat-and-extend regimen
    Hatz, Katja
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [37] Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
    Yang, Shiqi
    Zhao, Jingke
    Sun, Xiaodong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 1857 - 1867
  • [38] Peripapillary and macular microvasculature in neovascular age-related macular degeneration in long-term and recently started anti-VEGF therapy versus healthy controls
    Tuerksever, Cengiz
    Hoffmann, Laura
    Hatz, Katja
    FRONTIERS IN MEDICINE, 2023, 9
  • [39] Long-term changes in retinal layers in patients undergoing intravitreal ranibizumab for neovascular age-related macular degeneration: Retinal layers after anti-VEGF therapy
    Inan, Umit Ubeyt
    Baysal, Zeki
    Inan, Sibel
    INTERNATIONAL OPHTHALMOLOGY, 2019, 39 (12) : 2721 - 2730
  • [40] Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
    Armendariz, Beatriz G.
    Chakravarthy, Usha
    EYE, 2024, 38 (17) : 3243 - 3251
12345